NIH Blue Ribbon Panel

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Office of Biotechnology Activities; Office of Science Policy;
Office of the Director; Notice of a Meeting of the NIH Blue Ribbon
Panel

The purpose of this notice is to inform the public about a meeting
of the NIH Blue Ribbon Panel to Advise on the Risk Assessment of the
National Emerging Infectious Diseases Laboratories at Boston University
Medical Center.
There will be a meeting of the NIH Blue Ribbon Panel to advise on
the Risk Assessment of the National Emerging Infectious Diseases
Laboratories (NEIDL) at Boston University Medical Center. The meeting
will be held on Friday, February 12, 2010, at the Hyatt Regency
Bethesda Hotel, located at 7400 Wisconsin Avenue, Bethesda, Maryland
20814, from approximately 8:30 a.m. to 2 p.m. This meeting is the
second in a series of public meetings with the National Research
Council to review the ongoing supplementary risk assessment study.
Sign up for public comment will begin at approximately 8 a.m. In
the event that time does not allow for all those interested in
presenting oral comments, anyone may file written comments using the
following address below.
An agenda and slides for the meeting can be obtained prior to the
meeting by connecting to
http://nihblueribbonpanel-bumc-neidl.od.nih.gov/. For additional information concerning this meeting,
contact Ms. Laurie Lewallen, Advisory Committee Coordinator, Office of
Biotechnology Activities, Office of Science Policy, Office of the
Director, National Institutes of Health, 6705 Rockledge Drive, Room
750, Bethesda, MD 20892-7985; telephone 301-496-9838; e-mail
lewallenl@od.nih.gov.

Dated: January 11, 2010.
Kelly R. Fennington,
Special Assistant to the Director, Office of Biotechnology Activities,
National Institutes of Health.
[FR Doc. 2010-730 Filed 1-14-10; 8:45 am]
BILLING CODE 4140-01-P